These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 11127443

  • 1. Antiremodeling effects on the left ventricle during beta-blockade with metoprolol in the treatment of chronic heart failure.
    Groenning BA, Nilsson JC, Sondergaard L, Fritz-Hansen T, Larsson HB, Hildebrandt PR.
    J Am Coll Cardiol; 2000 Dec; 36(7):2072-80. PubMed ID: 11127443
    [Abstract] [Full Text] [Related]

  • 2. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group.
    Hjalmarson A, Goldstein S, Fagerberg B, Wedel H, Waagstein F, Kjekshus J, Wikstrand J, El Allaf D, Vítovec J, Aldershvile J, Halinen M, Dietz R, Neuhaus KL, Jánosi A, Thorgeirsson G, Dunselman PH, Gullestad L, Kuch J, Herlitz J, Rickenbacher P, Ball S, Gottlieb S, Deedwania P.
    JAMA; 2000 Mar 08; 283(10):1295-302. PubMed ID: 10714728
    [Abstract] [Full Text] [Related]

  • 3. Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction: the REversal of VEntricular Remodeling with Toprol-XL (REVERT) trial.
    Colucci WS, Kolias TJ, Adams KF, Armstrong WF, Ghali JK, Gottlieb SS, Greenberg B, Klibaner MI, Kukin ML, Sugg JE, REVERT Study Group.
    Circulation; 2007 Jul 03; 116(1):49-56. PubMed ID: 17576868
    [Abstract] [Full Text] [Related]

  • 4. Neurohumoral prediction of left-ventricular morphologic response to beta-blockade with metoprolol in chronic left-ventricular systolic heart failure.
    Groenning BA, Nilsson JC, Hildebrandt PR, Kjaer A, Fritz-Hansen T, Larsson HB, Sondergaard L.
    Eur J Heart Fail; 2002 Oct 03; 4(5):635-46. PubMed ID: 12413508
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The influence of renal function on clinical outcome and response to beta-blockade in systolic heart failure: insights from Metoprolol CR/XL Randomized Intervention Trial in Chronic HF (MERIT-HF).
    Ghali JK, Wikstrand J, Van Veldhuisen DJ, Fagerberg B, Goldstein S, Hjalmarson A, Johansson P, Kjekshus J, Ohlsson L, Samuelsson O, Waagstein F, Wedel H, MERIT-HF Study Group.
    J Card Fail; 2009 May 03; 15(4):310-8. PubMed ID: 19398079
    [Abstract] [Full Text] [Related]

  • 8. Metoprolol: a review of its use in chronic heart failure.
    Prakash A, Markham A.
    Drugs; 2000 Sep 03; 60(3):647-78. PubMed ID: 11030472
    [Abstract] [Full Text] [Related]

  • 9. Rationale, design, and organization of the Metoprolol CR/XL Randomized Intervention Trial in Heart Failure (MERIT-HF). The International Steering Committee.
    Am J Cardiol; 1997 Nov 13; 80(9B):54J-58J. PubMed ID: 9375952
    [Abstract] [Full Text] [Related]

  • 10. Atenolol is inferior to metoprolol in improving left ventricular function and preventing ventricular remodeling in dogs with heart failure.
    Zacà V, Rastogi S, Mishra S, Wang M, Sharov VG, Gupta RC, Goldstein S, Sabbah HN.
    Cardiology; 2009 Nov 13; 112(4):294-302. PubMed ID: 18832825
    [Abstract] [Full Text] [Related]

  • 11. Effects of long-term monotherapy with metoprolol CR/XL on the progression of left ventricular dysfunction and remodeling in dogs with chronic heart failure.
    Morita H, Suzuki G, Mishima T, Chaudhry PA, Anagnostopoulos PV, Tanhehco EJ, Sharov VG, Goldstein S, Sabbah HN.
    Cardiovasc Drugs Ther; 2002 Sep 13; 16(5):443-9. PubMed ID: 12652114
    [Abstract] [Full Text] [Related]

  • 12. Selective beta1-blockade attenuates post-infarct remodelling without improvement in myocardial energy metabolism and function in rats with heart failure.
    Omerovic E, Bollano E, Soussi B, Waagstein F.
    Eur J Heart Fail; 2003 Dec 13; 5(6):725-32. PubMed ID: 14675850
    [Abstract] [Full Text] [Related]

  • 13. Metoprolol controlled release/extended release in patients with severe heart failure: analysis of the experience in the MERIT-HF study.
    Goldstein S, Fagerberg B, Hjalmarson A, Kjekshus J, Waagstein F, Wedel H, Wikstrand J, MERIT-HF Study Group.
    J Am Coll Cardiol; 2001 Oct 13; 38(4):932-8. PubMed ID: 11583861
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinical studies on beta blockers and heart failure preceding the MERIT-HF Trial. Metoprolol CR/XL Randomized Intervention Trial in Heart Failure.
    Goldstein S.
    Am J Cardiol; 1997 Nov 13; 80(9B):50J-53J. PubMed ID: 9375951
    [Abstract] [Full Text] [Related]

  • 16. A randomized controlled phase IIb trial of beta(1)-receptor blockade for chronic degenerative mitral regurgitation.
    Ahmed MI, Aban I, Lloyd SG, Gupta H, Howard G, Inusah S, Peri K, Robinson J, Smith P, McGiffin DC, Schiros CG, Denney T, Dell'Italia LJ.
    J Am Coll Cardiol; 2012 Aug 28; 60(9):833-8. PubMed ID: 22818065
    [Abstract] [Full Text] [Related]

  • 17. Hemodynamic and energetic comparison of bucindolol and metoprolol for the treatment of congestive heart failure.
    Heesch CM, Marcoux L, Hatfield B, Eichhorn EJ.
    Am J Cardiol; 1995 Feb 15; 75(5):360-4. PubMed ID: 7856528
    [Abstract] [Full Text] [Related]

  • 18. Increased exercise ejection fraction and reversed remodeling after long-term treatment with metoprolol in congestive heart failure: a randomized, stratified, double-blind, placebo-controlled trial in mild to moderate heart failure due to ischemic or idiopathic dilated cardiomyopathy.
    Waagstein F, Strömblad O, Andersson B, Böhm M, Darius M, Delius W, Goss F, Osterziel KJ, Sigmund M, Trenkwalder SP, Wahlqvist I.
    Eur J Heart Fail; 2003 Oct 15; 5(5):679-91. PubMed ID: 14607208
    [Abstract] [Full Text] [Related]

  • 19. Effects of long-term adrenergic beta-blockade on left ventricular diastolic filling in patients with acute myocardial infarction.
    Poulsen SH, Jensen SE, Egstrup K.
    Am Heart J; 1999 Oct 15; 138(4 Pt 1):710-20. PubMed ID: 10502218
    [Abstract] [Full Text] [Related]

  • 20. Tolerability of beta-blocker initiation and titration in the Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF).
    Gottlieb SS, Fisher ML, Kjekshus J, Deedwania P, Gullestad L, Vitovec J, Wikstrand J, MERIT-HF Investigators.
    Circulation; 2002 Mar 12; 105(10):1182-8. PubMed ID: 11889011
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.